We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Smart Capsule Delivers Payload to Large Intestines

By HospiMedica International staff writers
Posted on 15 Sep 2015
An innovative drug delivery capsule could deliver drugs directly to the gastrointestinal (GI) tract to target certain medical conditions.

Developed by researchers at Purdue University (West Lafayette, IN, USA), the 9×26 mm capsule is comprised of two compartments; one contains a charged capacitor and a reed switch, while the second one houses the drug reservoir, capped by a taut nylon thread intertwined with a nichrome wire connected to the capacitor through the reed switch. More...
The capsule meanders through the intestines until it reaches the target location within the GI tract, which is marked by an implanted miniature magnetic marker or an externally-worn larger magnet.

The proximity to the magnet activates the reed switch, which discharges the capacitor into the nichrome wire, melting the nylon thread. This releases a spring-loaded mechanism that opens the capped capsule to deliver the medication. A prototype capsule, about the same size as a standard gelatin capsule, was designed to release its powdered payload just before reaching the ileocecal valve, the meeting point of small and large intestines. A study describing the capsule was published in the September 2015 issue of IEEE Transactions on Biomedical Engineering.

“Usually, when you take medication it is absorbed in the stomach and small intestine before making it to the large intestine; however, there are many medications that you would like to deliver specifically to the large intestine, and a smart capsule is an ideal targeted-delivery vehicle for this,” said senior author, Professor of electrical and computer engineering Babak Ziaie, PhD. “People are sometimes treated for C. difficile by transplanting feces from another person into the patient's large intestine, which provides vital microbes. However, it might be possible to convert the microbes into a powder through freeze-drying and deliver them with smart capsules instead.”

Related Links:

Purdue University



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Infrared Digital Thermometer
R1B1
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.